GGrantIndex
Sort

326,823 grants matching clinical trial

Development of transapical MVAD for heart failure therapy

$1,729,014
Daniel Tamez · Heartware, Inc. · R44 · FY2013 · HL

Diabetes Prevention Program Outcomes Study

$1,729,000
Marinella Temprosa · George Washington University · U01 · FY2013 · DK

Diagnosis and Risk factors of hippocampal sclerosis of aging and limbic predominant age related TDP-43 encephalopathy; common Alzheimer’s mimics

$1,728,882
Seyed Ahmad Sajjadi · University Of California-Irvine · R01 · FY2025 · AG

Impact of Smoking on Lung Cancer Chemoprevention

$1,728,827
University Of Texas Md Anderson Can Ctr · P01 · FY2005 · CA

ROMICAT II - CCC - Lead Application

$1,728,807
Udo Hoffmann · Massachusetts General Hospital · U01 · FY2009 · HL

Treatment of Acute Lung Injury and Acute Respiratory Distress Syndrome

$1,728,781
David A Schoenfeld · Massachusetts General Hospital · N01 · FY2011 · HL

CTSA INFRASTRUCTURE FOR CLINICAL TRIALS

$1,728,759
Robert Daniel Toto · Ut Southwestern Medical Center · UL1 · FY2011 · RR

Clinical Trials

$1,728,710
Ronald Gress · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA

North Carolina Clinical Genomic Evaluation by Next-gen Exome Sequencing 2

$1,728,692
Jonathan S Berg · Univ Of North Carolina Chapel Hill · U01 · FY2021 · HG

Predictive Personalized Public Health (P3H): A Novel Paradigm to Treat Infectious Disease

$1,728,465
Steven J. Schiff · Yale University · R01 · FY2022 · AI

Human Disease-Specific Induced Pluripotent Stem Cells For Preclinical Drug Testing and Drug Discovery

$1,728,439
Lynne A Bui · Khloris Biosciences, Inc. · R44 · FY2022 · HL

Washington University Institute of Clinical and Translational Sciences (KL2)

$1,728,410
Kenneth S Polonsky · Washington University · KL2 · FY2009 · RR

Elafin Therapy for Pulmonary Arterial Hypertension

$1,728,355
Marlene Rabinovitch · Stanford University · P01 · FY2019 · HL

Pro-inflammatory cytokine lowering anti-inflammatory drugs

$1,728,312
Nigel H. Greig · National Institute On Aging · ZIA · FY2018 · AG

Development of contrast agents to facilitate image-guided surgery

$1,728,268
Lacey R McNally · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2025 · CA

Novel Antagonists of the N-terminal Domain of the CRF Receptor Type 1 for Alzheimer's Disease

$1,728,235
Robert A Rissman · Veterans Medical Research Fdn/San Diego · RF1 · FY2020 · AG

The LIMIting AAA with meTformin (LIMIT) Trial

$1,728,178
Ronald L Dalman · Stanford University · R33 · FY2023 · HL

Genomics for Kidney Transplantation

$1,728,049
Daniel Rene Salomon · Scripps Research Institute, The · U19 · FY2010 · AI

Penn State University's Translational Center for Child Maltreatment Studies TCCMS

$1,727,990
Jennie G Noll · Pennsylvania State University, The · P50 · FY2021 · HD

Genomic Ascertainment - Clinical and Behavioral Aspects

$1,727,897
Leslie Biesecker · National Human Genome Research Institute · ZIA · FY2020 · HG

Rare & Mosaic Disorders - Clinical Research

$1,727,897
Leslie Biesecker · National Human Genome Research Institute · ZIA · FY2020 · HG

Rare & Mosaic Disorders Molecular Research

$1,727,897
Leslie Biesecker · National Human Genome Research Institute · ZIA · FY2020 · HG

Michigan Prostate SPORE

$1,727,892
Arul M Chinnaiyan · University Of Michigan At Ann Arbor · P50 · FY2022 · CA

Michigan Prostate SPORE

$1,727,891
Arul M Chinnaiyan · University Of Michigan At Ann Arbor · P50 · FY2021 · CA

Cardiovascular CT Clinical Research

$1,727,854
Marcus Chen · National Heart, Lung, And Blood Institute · ZIA · FY2022 · HL